These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4660365)

  • 41. [Cholera and typhus vaccination].
    Stickl H
    Dtsch Med Wochenschr; 1969 Jul; 94(27):1425. PubMed ID: 5787362
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003.
    Kabir S
    Vaccine; 2007 Feb; 25(8):1353-4. PubMed ID: 17049687
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effectiveness of cholera vaccine].
    Joó I
    Z Gesamte Hyg; 1972 Oct; 18(10):762-4. PubMed ID: 4667242
    [No Abstract]   [Full Text] [Related]  

  • 45. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
    Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
    Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Massive complex (combined) immunization against typhoid, cholera and plague].
    Agafonov VI; Gapochko KG; Gamleshko KhP; Mokrousov VB; Titova TS
    Voen Med Zh; 1983 Aug; (8):45-8. PubMed ID: 6636577
    [No Abstract]   [Full Text] [Related]  

  • 48. Ineffectiveness of cholera vaccination as an epidemic control measure.
    Sommer A; Mosley WH
    Lancet; 1973 Jun; 1(7814):1232-5. PubMed ID: 4122575
    [No Abstract]   [Full Text] [Related]  

  • 49. [Neurologic complications due to anticholera vaccine].
    Scoleri G; Sepe O; Tecce V; Valiani R
    Acta Neurol (Napoli); 1974; 29(5):505-10. PubMed ID: 4155916
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of intradermal and subcutaneous routes of cholera vaccine administration.
    McBean AM; Agle AN; Compaore P; Foster SO; McCormack WM
    Lancet; 1972 Mar; 1(7749):527-9. PubMed ID: 4110029
    [No Abstract]   [Full Text] [Related]  

  • 51. [Case of transverse myelitis induced by anticholera vaccination].
    Granata F; Graziussi G; De Carlo C; Taglialatela G
    Acta Neurol (Napoli); 1974; 29(5):511-5. PubMed ID: 4451167
    [No Abstract]   [Full Text] [Related]  

  • 52. [Standardization of chemical cholerogen-toxoid cholera vaccine according to the content of somatic O-antigen].
    Sumarokov AA; Dzhaperidze MN; Ivanov NR; Karaeva LT; Popov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):99-106. PubMed ID: 405829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [30 cases of neuropsychiatric complications after anticholera vaccination].
    Viparelli U; Pannone B; Sciorio G
    Acta Neurol (Napoli); 1974; 29(5):520-33. PubMed ID: 4451168
    [No Abstract]   [Full Text] [Related]  

  • 54. [Case of leukoencephalomyelitis due to anticholera vaccine].
    Gentile A; Caruso C
    Acta Neurol (Napoli); 1974; 29(5):516-9. PubMed ID: 4155917
    [No Abstract]   [Full Text] [Related]  

  • 55. Overprescription of cholera vaccine.
    BMJ; 1990 Jan; 300(6719):257-8. PubMed ID: 2106941
    [No Abstract]   [Full Text] [Related]  

  • 56. [Apropos of cholera and anticholera vaccination as discussed at the symposium organized by WHO in Bamako (Mali) in March 1972].
    De Maeyer-Cleempoel S
    Arch Belg Med Soc; 1972 Jun; 30(6):380-93. PubMed ID: 4143906
    [No Abstract]   [Full Text] [Related]  

  • 57. Leads from the MMWR. Cholera vaccine.
    JAMA; 1988 Nov; 260(17):2489-90. PubMed ID: 3172419
    [No Abstract]   [Full Text] [Related]  

  • 58. Induced human cholera.
    Music SI; Libonati JP; Wenzel RP; Snyder MJ; Hornick RB; Woodward TE
    Antimicrob Agents Chemother (Bethesda); 1970; 10():462-6. PubMed ID: 5521368
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on the cholera toxin.
    Ungar J; Chariatte N; Stanić M; Varallyay S
    Prog Immunobiol Stand; 1967; 3():357-62. PubMed ID: 4985515
    [No Abstract]   [Full Text] [Related]  

  • 60. Cholera vaccine evaluation.
    Epidemiol Bull; 1991; 12(2):11-4. PubMed ID: 1911067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.